NOVARTIS CAMPUS a VISION detailed regulation...or... just goals for legal energetic requirements
Modification of strategies at the level of implementation of energy law: 1994:"Actions(PR) instead of control" 2003: gools inst. of reglementation 1400 1200 1000 numbers 800 600 HCV-Instalations Applications 400 200 0 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 subsidies Buildings year F9
NOVARTIS CAMPUS a VISION Elements of the energy-agreement between Local Authorities and NOVARTIS from 2. Februar 2004 1. Allowed Specific Energy Consume (SEC) for each building thermic energy (MJ/m2*a) electrical energy (MJ/m2*a) 2. Annual energetic balance of each building using Bonus/Malus 3. A Malus of 7.5% at the maximum (for the total CAMPUS-area) may be compensated with renewable F2
NOVARTIS CAMPUS eine VISION Limit set according agreement Excess consume to be covered by renewables Max. 7.5 % Excess consum + Electricity Strom and thermal und e. Wärme [MJ/m 2 *a] [MJ/m 2 *a] Electricity Strom and thermal und e. Wärme [MJ/m 2 *a] [MJ/m 2 *a] Set- gool / target value Real achieved value F7
Specific Energy Consumption (MJ/m2*a) based on standards of SIA* electric E e SIA 380/ 4 +!! Light / HCV / Equipment Q f SIA 380/ 1 solar gains persons thermal E th heating hot water loss Swiss (I)Engineering Association F3
NOVARTIS CAMPUS a VISION Specific Energy Consumption for each building At least. 8% below bench-mark SEC el SEC th Restaurant offices offices Reception/ lobby Audience-hall Total SEC building n F3
SEC- thermic of 100 administrative buildings 1000 900 Building with HCV Building partly with HCV No Clima; no Ventilation 800 700 [MJ/m2a] 600 500 400 300 CAMPUS-agreement 150 MJ/m2*a 200 100 0 1 11 21 31 41 51 61 71 81 91 Quelle :Studie ETH; Energieverbrauch von 100 Verwaltungsbauten
SEC - electricity of 100 administrative buildings 1400 1200 1000 Buildings with HCV Buildings partly with HCV No Climatisation no Ventilation [MJ/m2a] 800 600 400 CAMPUS-agreement 150 MJ/m2*a 200 0 1 11 21 31 41 51 61 71 81 91 source: study by ETH; energy consumption of 100 admin. buildings
CAMPUS LAB s Base for discussion SEC for thermal energy (MJ/m2*a) SEC datas of different Labs in Switzerland 3/4 1 2 analytical Bio <20%animals 2 3 Bio>50% animals 1 4 chemical SEC for thermal energy (MJ/m2*a) SEC for electricity F4
NOVARTIS CAMPUS eine VISION Annual adjustment for thr whole CAMPUS-area CAMPUS area = Delimination of energg.-balance B1 B2 B3 B4 B5 n n n n Bn SEC el SEC th Bonus/ Malus B1 ++ B2 - B3 - Bn Total Comparison goal / eff.result Compensation with renewables (max.7.5%) F7
Advantages and desadvantages of traditional and applied new CAMPUS-model Traditionally Model aplied in CAMPUS administrative Application for a construction-project compiling controling setting of obligations site visit grant of authorization...loose of control! determine SEC s for each building with authorities gool-orientated No feedback continuous revew of achievement monitoring / reporting... each year.
Nachhaltigkeit von Glas- vs. konventioneller Architektur*? 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 Betriebsenergie Transporte ab Lieferant Fassade, Fensterrahmen Verglasung, Storen Lochfassade, 700 MJ/m2, Strom / FW Lochfassade, 300 MJ/m2, Strom / FW Glasfassade, 300 MJ/m2, Strom / FW Lochfassade, 300 MJ/m2, Strom / Gas Glasfassade, 300 MJ/m2, Strom / Gas Umweltbelastung Eco-indicator 99 (H/A) Punkte pro m 2 EBF und Jahr Massive Bauteile, Stützen Berechnungsvariante *Vorläufiges Ergebnis eine Studie der FHBB im Auftrag von AUE und Novartis
Nachhaltigkeit von Glas- vs. konventioneller Architektur*? Umweltbelastung Eco-indicator 99 Punkte pro m 2 EBF und Jahr 0.25 0.20 0.15 0.10 0.05 0.00 Märkli Gebäude, orginal Märkli Gebäude, Verglasung stark Märkli Gebäude, Verglasung nur 2-fach Märkli Gebäude, Alu 85% Recycling Referenzgebäude mit Lochfassade Transporte ab Lieferant Ornamentgitter Metalllfasade, Fensterrahmen Storenabdeckungen, Vorhangfassade Sonnenstoren Verglasung Stützenverkleidung Massive Bauteile, Stützen Berechnungsvariante *Vorläufiges Ergebnis eine Studie der FHBB im Auftrag von AUE und Novartis